BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
1216 results:

  • 1. PI3K/Akt/mtor Signaling Pathway as a Target for colorectal cancer Treatment.
    Leiphrakpam PD; Are C
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542151
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
    Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mtor signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]    [Full Text] [Related]  

  • 4. Broccoli extracellular vesicles enhance the therapeutic effects and restore the chemosensitivity of 5-fluorouracil on colon cancer.
    Cao Y; Hou L; Li M; Zhang J; Wang L; Liu C; Luo T; Yan L; Zheng L
    Food Chem Toxicol; 2024 Apr; 186():114563. PubMed ID: 38442787
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in colorectal cancer.
    Zheng W; Chen K; Lv Y; Lao W; Zhu H
    Anticancer Res; 2024 Mar; 44(3):1193-1199. PubMed ID: 38423653
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Selective Synergy of Rapamycin Combined With Methioninase on cancer Cells Compared to Normal Cells.
    Ardjmand D; Kubota Y; Sato M; Han Q; Mizuta K; Morinaga S; Hoffman RM
    Anticancer Res; 2024 Mar; 44(3):929-933. PubMed ID: 38423628
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
    Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
    Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TMEM97 knockdown inhibits 5-fluorouracil resistance by regulating epithelial-mesenchymal transition and ABC transporter expression via inactivating the Akt/mtor pathway in 5-fluorouracil-resistant colorectal cancer cells.
    Xu Y; Tang Y; Xu Q; He W
    Chem Biol Drug Des; 2024 Feb; 103(2):e14490. PubMed ID: 38388887
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The pathogenicity of vancomycin-resistant Enterococcus faecalis to colon cancer cells.
    Zhang L; Deng M; Liu J; Zhang J; Wang F; Yu W
    BMC Infect Dis; 2024 Feb; 24(1):230. PubMed ID: 38378500
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A free fatty acid receptor agonist inducing autophagy in HT-29 cells by downregulating the AKT/mtor signaling pathway.
    Hoveizi E; Rafienia B; Shahriari A
    J Cancer Res Ther; 2023 Oct; 19(7):1931-1938. PubMed ID: 38376299
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mtor pathway and is a therapeutic target.
    Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
    Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Everolimus exerts anticancer effects through inhibiting the interaction of matrix metalloproteinase-7 with syndecan-2 in colon cancer cells.
    Lee S; Jang B; Hwang J; Lee Y; Cho S; Yang H; Yun JH; Shin DH; Lee W; Oh ES
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1067-C1079. PubMed ID: 38314724
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
    Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
    J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs.
    Abd El-Hafeez T; Shams MY; Elshaier YAMM; Farghaly HM; Hassanien AE
    Sci Rep; 2024 Jan; 14(1):2428. PubMed ID: 38287066
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/AKT/mtor pathway.
    Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
    Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Deletion of IL-27p28 induces CD8 T cell immunity against colorectal tumorigenesis.
    Li P; Pu S; Yi J; Li X; Wu Q; Yang C; Kang M; Peng F; Zhou Z
    Int Immunopharmacol; 2024 Feb; 128():111464. PubMed ID: 38224627
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Roles of Rictor alterations in gastrointestinal tumors (Review).
    Cao R; Guo S; Min L; Li P
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186315
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MAD2L2, a key regulator in ovarian cancer and promoting tumor progression.
    Xu K; Zheng X; Shi H; Ou J; Ding H
    Sci Rep; 2024 Jan; 14(1):130. PubMed ID: 38167649
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mtor pathway.
    Ling J; Li X; Wang M; Zhang C; Liu Y; Zhang X; Liu C; Ren Q; Zeng Y; Wang C; Chen Y; Sun C; Chen H; Zuo Y; Cao X; Deng Y; Ren B; Li D; Lu J
    Bioorg Chem; 2024 Feb; 143():107069. PubMed ID: 38160477
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long non-coding RNA NBR2 suppresses the progression of colorectal cancer by downregulating miR-19a to regulate M2 macrophage polarization.
    Yang X; Luo Y; Li M; Jin Z; Chen G; Gan C
    Chin J Physiol; 2023; 66(6):546-557. PubMed ID: 38149567
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 61.